Trials / Completed
CompletedNCT04662411
Butyrate/Hexanoate in Metabolic Health
Butyrate/Hexanoate-enriched Triglycerides for Metabolic Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- Male
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
In this study, we aim to identify a well consumable butyrate/hexanoate-enriched oil that increases circulating SCFA concentrations and improves postprandial substrate metabolism, which could be further used for a long-term study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | acute intake of 0 mg butyrate and hexanoate |
| DIETARY_SUPPLEMENT | butyrate and hexanoate amount 1 | acute intake of 650 mg butyrate and hexanoate |
| DIETARY_SUPPLEMENT | butyrate and hexanoate amount 2 | acute intake of 1325 mg butyrate and hexanoate |
| DIETARY_SUPPLEMENT | butyrate and hexanoate amount 3 | acute intake of 2000 mg butyrate and hexanoate |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2021-07-26
- Completion
- 2021-07-26
- First posted
- 2020-12-10
- Last updated
- 2021-11-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04662411. Inclusion in this directory is not an endorsement.